Telerehabilitation in Disabled People: Proposal for Practical Intervention With Virtual Reality
- Disease/Condition
- Disability Physical
- Drug/Device/Intervention
- Application of tele-rehabilitation
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- University of Sao Paulo
- Location
- Sao Paulo, Brazil
- Phase
- N/A
- Start date
- May 15, 2020
- End date
- Oct 21, 2020
- Enrollment
- 40 participants
Motor performance.
This is a cross-sectional study, that is going to be conducted during the quarantine, period
 established by the state of São Paulo to reduce the transmission of COVID-19, between March
 24 2020 and May 31 2020. Thus, the differential of this study is to use 100%
 telerehabilitation, in which the rehabilitation team and participants only had telephone
 contact, communication application (WhatsApp) and software interaction. 40 participants will
 be included. Potential and interested volunteers will be assessed by a detailed screening
 using the eligibility criteria and attended an initial selection for enrolment in the study.
 It wiil be used a platform called MoveHero, available for free use in
 https://movehero.com.br/. The individual needs access the internet, and once he gets online,
 he had to create his own account, inserting his name, email and creating a password.
 Considering that the platform presents different levels of difficulty, after the participant
 is connected to the platform, the researcher directed the participant to the protocol bespoke
 for each participant, playing 3 rounds of the game for 5 minutes each (total of 15 minutes).
 During the intervention, it will be applied BORG scale in order to assess their perceived
 effort.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04402034
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT04402034 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Sao Paulo and is currently Completed. The study focuses on Disability Physical. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.